Matches in Wikidata for { <http://www.wikidata.org/entity/Q91199324> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- Q91199324 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q91199324 description "scientific article published on 29 August 2018" @default.
- Q91199324 description "wetenschappelijk artikel" @default.
- Q91199324 description "наукова стаття, опублікована в серпні 2018" @default.
- Q91199324 description "գիտական հոդված հրատարակված 2018 թվականի օգոստոսի 29-ին" @default.
- Q91199324 name "Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer" @default.
- Q91199324 name "Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer" @default.
- Q91199324 type Item @default.
- Q91199324 label "Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer" @default.
- Q91199324 label "Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer" @default.
- Q91199324 prefLabel "Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer" @default.
- Q91199324 prefLabel "Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer" @default.
- Q91199324 P1433 Q91199324-0B14FBE4-EF57-44AD-8DBB-BA4AE352E8D3 @default.
- Q91199324 P1476 Q91199324-5B3FAD15-5452-4625-8B40-FFB6F11DA596 @default.
- Q91199324 P2093 Q91199324-2581D25A-A297-4A4A-B91C-7FF6CE0D0467 @default.
- Q91199324 P2093 Q91199324-263D1CF1-5367-4473-B957-26B4A3812E7A @default.
- Q91199324 P2093 Q91199324-4268A446-0C41-45C4-8DF0-5D7805E6E2EF @default.
- Q91199324 P2093 Q91199324-4A7B8353-13BB-43C9-AF37-5B3D69773056 @default.
- Q91199324 P2093 Q91199324-6E21B565-860C-4A78-9EE1-340D138F5646 @default.
- Q91199324 P2093 Q91199324-762445EA-927D-4D03-B5D6-5634DB1DA2E3 @default.
- Q91199324 P2093 Q91199324-7F01E667-829C-4E41-AC57-0DEE820DD919 @default.
- Q91199324 P2093 Q91199324-8083EC72-6499-4890-AB5F-216BBC1A502D @default.
- Q91199324 P2093 Q91199324-8F6F2A3E-404F-4170-99D5-5CCE6972FC94 @default.
- Q91199324 P2093 Q91199324-A436ED4A-17A1-4C6B-AC24-D712A81A3066 @default.
- Q91199324 P2093 Q91199324-B4C508D1-7D5E-4A68-9A95-487185B64766 @default.
- Q91199324 P2093 Q91199324-D2CE7C56-53F7-40B8-9DF2-A32F575EF616 @default.
- Q91199324 P2093 Q91199324-D7D3B522-8848-4231-A363-74732DE90865 @default.
- Q91199324 P2093 Q91199324-E798AA9B-B400-45EF-B924-22163B888F67 @default.
- Q91199324 P2093 Q91199324-F7B5FA04-48B0-4587-B819-3D8DB4AD4428 @default.
- Q91199324 P2860 Q91199324-2D366454-E25B-4933-9EC5-8FEA8F48D662 @default.
- Q91199324 P304 Q91199324-D012988B-764A-49D0-9AA7-3FE258286E53 @default.
- Q91199324 P31 Q91199324-69B24804-6584-415B-8AF0-57BBC482E42B @default.
- Q91199324 P356 Q91199324-4B4C6402-19C2-4A18-8BC0-1F432BD7001B @default.
- Q91199324 P433 Q91199324-0B014467-51F2-4FA5-8F56-DA4C1EF28180 @default.
- Q91199324 P478 Q91199324-36DE2D85-EF07-40B9-8867-4FAE607738B2 @default.
- Q91199324 P50 Q91199324-3086304E-D35C-4236-98E4-CF65CC1B9B6F @default.
- Q91199324 P50 Q91199324-7766FFE0-BE7B-47A3-918E-14A0A7B544AC @default.
- Q91199324 P577 Q91199324-E1574C7B-447C-49E2-B4C4-F932266672DA @default.
- Q91199324 P698 Q91199324-EE1FC918-7DCC-472F-B270-9E4365D93F20 @default.
- Q91199324 P356 JCO.2018.77.7326 @default.
- Q91199324 P698 30156984 @default.
- Q91199324 P1433 Q400292 @default.
- Q91199324 P1476 "Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer" @default.
- Q91199324 P2093 "Bin Peng" @default.
- Q91199324 P2093 "Dae Ho Lee" @default.
- Q91199324 P2093 "Daniel S W Tan" @default.
- Q91199324 P2093 "Dong-Wan Kim" @default.
- Q91199324 P2093 "Johan F Vansteenkiste" @default.
- Q91199324 P2093 "Li Zhang" @default.
- Q91199324 P2093 "Mikhail Akimov" @default.
- Q91199324 P2093 "Myung-Ju Ahn" @default.
- Q91199324 P2093 "Philippe Pultar" @default.
- Q91199324 P2093 "Sabine Glaser" @default.
- Q91199324 P2093 "Sylvia Zhao" @default.
- Q91199324 P2093 "Vincent Chia" @default.
- Q91199324 P2093 "Wu-Chou Su" @default.
- Q91199324 P2093 "Xiaoqing Liu" @default.
- Q91199324 P2093 "Yi-Long Wu" @default.
- Q91199324 P2860 Q27851406 @default.
- Q91199324 P304 "3101-3109" @default.
- Q91199324 P31 Q13442814 @default.
- Q91199324 P356 "10.1200/JCO.2018.77.7326" @default.
- Q91199324 P433 "31" @default.
- Q91199324 P478 "36" @default.
- Q91199324 P50 Q37840097 @default.
- Q91199324 P50 Q56605610 @default.
- Q91199324 P577 "2018-08-29T00:00:00Z" @default.
- Q91199324 P698 "30156984" @default.